Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

HB 3086 requires pharmaceutical manufacturers selling prescription drugs in Texas to annually report the wholesale acquisition cost of each drug by January 15th each year. For drugs with a 40% or greater cost increase over three years (or 15% in one year), manufacturers must also disclose the reasons for the increase, research costs filed with the SEC, newly approved drugs, and drugs losing patent protection in the prior three years. The Texas Health and Human Services Department must publish this cost information on its public website within 60 days of receiving reports. Non-compliant manufacturers may face administrative penalties, and the law takes effect September 1, 2025.